RECEPTOR (IMMUNOPHILIN-BINDING) ASSAY FOR IMMUNOSUPPRESSIVE DRUGS

被引：15

作者：

SOLDIN, SJ

机构：

[1] GEORGE WASHINGTON UNIV,SCH MED,DEPT PEDIAT,WASHINGTON,DC 20052

[2] GEORGE WASHINGTON UNIV,SCH MED,DEPT PATHOL,WASHINGTON,DC 20052

来源：

THERAPEUTIC DRUG MONITORING | 1995年 / 17卷 / 06期

关键词：

IMMUNOPHILINS; CYCLOPHILIN; FK-BINDING PROTEIN; 14-KDA IMMUNOPHILIN; 52-KDA IMMUNOPHILIN; RECEPTOR ASSAYS; IMMUNOPHILIN-BINDING ASSAYS;

D O I：

10.1097/00007691-199512000-00005

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

The major immunophilins that bind cyclosporine (cyclophilin) and FK-506/rapamycin (FK-BP12) have been well characterized. They possess rotamase activity, which is inhibited by the immunosuppressant that binds to them. The immunosuppressive action does not appear to be coupled to rotamase activity. The literature on some possible mechanisms of immunosuppression is reviewed. Minor immunophilins of 14, 37, and 52 kDa have also been isolated and partially characterized. The 14-kDa immunophilin binds FK-506 and rapamycin whereas the 52-kDa immunophilin binds all three drugs. Neither of these proteins have rotamase activity. Receptor assays employing immunophilins have been developed. Preliminary results are encouraging indicating that they may possess some advantages over current immunoassay procedures.

引用

页码：574 / 576

页数：3

共 18 条

[1]

Batiuk T. D., 1994, Clinical and Investigative Medicine, V17, pB91

[2] 2 DISTINCT SIGNAL TRANSMISSION PATHWAYS IN LYMPHOCYTES-T ARE INHIBITED BY COMPLEXES FORMED BETWEEN AN IMMUNOPHILIN AND EITHER FK506 OR RAPAMYCIN [J].